Resultados de la búsqueda 241-250 of 8570 for immunosuppressant drugs
Subjects will be monitored for adverse events from the beginning of the study drug to 28 days after the last dose. We will collect blood samples for ...
Drugs used in chemotherapy regimens such as UH-3 (vincristine, doxorubicin, cyclophosphamide, carboplatin, etoposide, and irinotecan) and ICE/Cyclo/Topo ...
The purpose of this study is to assess the differences in microvascular anastomosis outcomes between the experiment aneurysmal subarachnoid hemorrhage (aSAH)- ...
Antes, las personas con trasplante de riñón generalmente tomaban esteroides (por ejemplo, prednisona) como uno de los medicamentos inmunosupresores para ...
Recently, a new medication called Tolvaptan has been approved by the FDA to slow progression of ADPKD. Accurate, MR based kidney volume measurements are the ...
Rochester, Minn., Jacksonville, Fla. The goal of this study is to provide access to axicabtagene ciloleucel for patients diagnosed with a disease approved for ...
Therapeutic drug monitoring of immunosuppressive drugs: A field constantly in motion. Therapeutic Drug Monitoring. 2025; doi:10.1097/FTD.0000000000001286 ...
AskMayoExpert. Obesity (adult). Mayo Clinic; 2018. Pilitsi E, et al. Pharmacotherapy of obesity: Available medications and drugs under investigation. Metabolism ...
We hypothesize that in displaced 3- and 4-part proximal humerus fractures, rTSA will have better pain relief and functional outcomes than nonoperative treatment ...
Mayo Clinic no respalda compañías ni productos. Las recaudaciones de los avisos comerciales financian nuestra misión sin fines de lucro.
Consulta estos éxitos de venta y ofertas especiales en libros y boletines informativos de Mayo Clinic Press.
¿Te gustaría hacer una donación deducible de impuestos y ser parte de una investigación de vanguardia y de una atención médica que transforma la medicina?